Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00057577 · ClinicalTrials.gov registry record · Phase 4
Prevention of Recurrence in Depression With Drugs and CT
A Phase 4 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 4
- Development phase
- 452
- Enrollment target
NCT00057577 is a Phase 4 study that has completed, run by Vanderbilt University. The registered enrollment target is 452 participants.
The verdict
NCT00057577, a Phase 4 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 452 participants
- Enrollment target
Study Summary
This study will determine whether the addition of Cognitive Therapy (CT) to antidepressant medication (ADM) enhances treatment for depression. This study will also test whether the addition of CT to ADM will prevent recurrences of depression after therapy is over.
Interventions
- BEHAVIORAL Cognitive Therapy
- DRUG Medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2002-10 |
| Est. Completion | 2014-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00057577
The ClinicalTrials.gov registry entry for NCT00057577 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 452 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Therapy is the first listed.
NCT00057577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00057577 about?
NCT00057577 is a clinical study titled "Prevention of Recurrence in Depression With Drugs and CT". This study will determine whether the addition of Cognitive Therapy (CT) to antidepressant medication (ADM) enhances treatment for depression. This study will also test whether the addition of CT to ADM will prevent recurrences of depression after therapy is over.
What is the current status of trial NCT00057577?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 452 participants. The study started on 2002-10. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00057577?
The interventions under investigation include: Cognitive Therapy (BEHAVIORAL), Medications (DRUG).
Who is sponsoring clinical trial NCT00057577?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.